Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
GLIS2
|
ENSG00000126603.4 | GLIS family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLIS2 | hg19_v2_chr16_+_4364762_4364762, hg19_v2_chr16_+_4382225_4382225 | -0.32 | 8.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_2903514 | 3.17 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
chr2_+_24272576 | 2.11 |
ENST00000380986.4
ENST00000452109.1 |
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
chr19_+_35645817 | 2.08 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_+_35645618 | 2.01 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr1_-_186649543 | 1.82 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
chr2_+_24272543 | 1.82 |
ENST00000380991.4
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
chr1_-_153348067 | 1.36 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chr1_-_28520447 | 1.31 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
chr7_-_73133959 | 1.27 |
ENST00000395155.3
ENST00000395154.3 ENST00000222812.3 ENST00000395156.3 |
STX1A
|
syntaxin 1A (brain) |
chr11_+_844067 | 1.16 |
ENST00000397406.1
ENST00000409543.2 ENST00000525201.1 |
TSPAN4
|
tetraspanin 4 |
chr20_+_44637526 | 1.12 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr22_+_31489344 | 1.12 |
ENST00000404574.1
|
SMTN
|
smoothelin |
chr19_+_45409011 | 1.10 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr2_+_37571717 | 1.10 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
chr12_+_57853918 | 1.05 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
chr19_+_54372639 | 0.94 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
chr1_-_40157345 | 0.94 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
chr19_+_17858509 | 0.94 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
chr11_-_64646086 | 0.93 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
chr6_-_39290316 | 0.90 |
ENST00000425054.2
ENST00000373227.4 ENST00000373229.5 ENST00000437525.2 |
KCNK16
|
potassium channel, subfamily K, member 16 |
chr19_+_45349432 | 0.88 |
ENST00000252485.4
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
chr22_+_23264766 | 0.88 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr8_+_27183033 | 0.86 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr17_-_76921459 | 0.83 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr2_-_27718052 | 0.82 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr19_+_45418067 | 0.80 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr12_+_119616447 | 0.80 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr5_-_176836577 | 0.78 |
ENST00000253496.3
|
F12
|
coagulation factor XII (Hageman factor) |
chr2_+_37571845 | 0.77 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
chr7_+_2671663 | 0.76 |
ENST00000407643.1
|
TTYH3
|
tweety family member 3 |
chr6_-_39290744 | 0.75 |
ENST00000507712.1
|
KCNK16
|
potassium channel, subfamily K, member 16 |
chr17_+_41476327 | 0.75 |
ENST00000320033.4
|
ARL4D
|
ADP-ribosylation factor-like 4D |
chrX_-_153602991 | 0.74 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
chr1_-_24127256 | 0.73 |
ENST00000418277.1
|
GALE
|
UDP-galactose-4-epimerase |
chr19_+_17858547 | 0.72 |
ENST00000600676.1
ENST00000600209.1 ENST00000596309.1 ENST00000598539.1 ENST00000597474.1 ENST00000593385.1 ENST00000598067.1 ENST00000593833.1 |
FCHO1
|
FCH domain only 1 |
chr13_-_20767037 | 0.69 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
chr1_-_6550625 | 0.68 |
ENST00000377725.1
ENST00000340850.5 |
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr5_-_1524015 | 0.68 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
chr8_+_27182862 | 0.68 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
chr19_-_55652290 | 0.67 |
ENST00000589745.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr19_+_11200038 | 0.66 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
chr16_+_70680439 | 0.63 |
ENST00000288098.2
|
IL34
|
interleukin 34 |
chr19_+_54369608 | 0.63 |
ENST00000336967.3
|
MYADM
|
myeloid-associated differentiation marker |
chr2_+_114737472 | 0.62 |
ENST00000420161.1
|
AC110769.3
|
AC110769.3 |
chr1_-_156675535 | 0.62 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr7_+_77167343 | 0.60 |
ENST00000433369.2
ENST00000415482.2 |
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr22_-_28197486 | 0.60 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
chr8_+_38243951 | 0.60 |
ENST00000297720.5
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr22_-_30685596 | 0.59 |
ENST00000404953.3
ENST00000407689.3 |
GATSL3
|
GATS protein-like 3 |
chr21_-_31869451 | 0.59 |
ENST00000334058.2
|
KRTAP19-4
|
keratin associated protein 19-4 |
chr13_+_110959598 | 0.58 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr19_+_48824711 | 0.57 |
ENST00000599704.1
|
EMP3
|
epithelial membrane protein 3 |
chr1_-_19229248 | 0.57 |
ENST00000375341.3
|
ALDH4A1
|
aldehyde dehydrogenase 4 family, member A1 |
chr19_+_48828582 | 0.57 |
ENST00000270221.6
ENST00000596315.1 |
EMP3
|
epithelial membrane protein 3 |
chr19_-_41859814 | 0.56 |
ENST00000221930.5
|
TGFB1
|
transforming growth factor, beta 1 |
chr19_-_42931567 | 0.55 |
ENST00000244289.4
|
LIPE
|
lipase, hormone-sensitive |
chr19_+_45417504 | 0.55 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
chr19_-_46405861 | 0.55 |
ENST00000322217.5
|
MYPOP
|
Myb-related transcription factor, partner of profilin |
chr19_-_45661995 | 0.54 |
ENST00000438936.2
|
NKPD1
|
NTPase, KAP family P-loop domain containing 1 |
chr16_-_32688053 | 0.54 |
ENST00000398682.4
|
TP53TG3
|
TP53 target 3 |
chr10_-_33623564 | 0.53 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
chr9_+_139847347 | 0.53 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr22_-_21482046 | 0.52 |
ENST00000419447.1
|
POM121L7
|
POM121 transmembrane nucleoporin-like 7 |
chr21_+_34775698 | 0.52 |
ENST00000381995.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr16_+_27078219 | 0.51 |
ENST00000418886.1
|
C16orf82
|
chromosome 16 open reading frame 82 |
chr16_-_29910365 | 0.51 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr7_+_77167376 | 0.51 |
ENST00000435495.2
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr22_-_46931191 | 0.51 |
ENST00000454637.1
|
CELSR1
|
cadherin, EGF LAG seven-pass G-type receptor 1 |
chr1_-_156675368 | 0.50 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr3_-_48130314 | 0.50 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
chr14_+_94640633 | 0.50 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr22_-_21482352 | 0.50 |
ENST00000329949.3
|
POM121L7
|
POM121 transmembrane nucleoporin-like 7 |
chr11_-_2160180 | 0.50 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr22_-_50700140 | 0.49 |
ENST00000215659.8
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr2_-_89310012 | 0.49 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr20_-_23969416 | 0.49 |
ENST00000335694.4
|
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
chr6_-_43484718 | 0.47 |
ENST00000372422.2
|
YIPF3
|
Yip1 domain family, member 3 |
chr2_+_102508955 | 0.47 |
ENST00000414004.2
|
FLJ20373
|
FLJ20373 |
chr16_+_3070313 | 0.47 |
ENST00000326577.4
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr1_+_148928291 | 0.46 |
ENST00000420597.1
ENST00000452399.1 ENST00000294715.2 ENST00000539543.1 |
RP11-14N7.2
|
RP11-14N7.2 |
chr19_+_45417921 | 0.46 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr16_+_32264040 | 0.46 |
ENST00000398664.3
|
TP53TG3D
|
TP53 target 3D |
chr12_-_51785182 | 0.46 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chr10_-_75634219 | 0.45 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
chr3_+_111578131 | 0.44 |
ENST00000498699.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
chr22_+_18834324 | 0.44 |
ENST00000342005.4
|
AC008132.13
|
Uncharacterized protein |
chr16_+_3070356 | 0.44 |
ENST00000341627.5
ENST00000575124.1 ENST00000575836.1 |
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr16_+_57279248 | 0.43 |
ENST00000562023.1
ENST00000563234.1 |
ARL2BP
|
ADP-ribosylation factor-like 2 binding protein |
chr19_+_45417812 | 0.43 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
chr17_-_5138099 | 0.43 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr11_-_64546202 | 0.43 |
ENST00000377390.3
ENST00000227503.9 ENST00000377394.3 ENST00000422298.2 ENST00000334944.5 |
SF1
|
splicing factor 1 |
chr7_+_116166331 | 0.42 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr17_+_7210898 | 0.42 |
ENST00000572815.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr4_+_37828255 | 0.42 |
ENST00000381967.4
ENST00000544359.1 ENST00000537241.1 |
PGM2
|
phosphoglucomutase 2 |
chr5_+_169010638 | 0.42 |
ENST00000265295.4
ENST00000506574.1 ENST00000515224.1 ENST00000508247.1 ENST00000513941.1 |
SPDL1
|
spindle apparatus coiled-coil protein 1 |
chr4_-_48082192 | 0.42 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
chr22_-_39640756 | 0.41 |
ENST00000331163.6
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr11_+_86748998 | 0.41 |
ENST00000525018.1
ENST00000355734.4 |
TMEM135
|
transmembrane protein 135 |
chrX_+_53078273 | 0.41 |
ENST00000332582.4
|
GPR173
|
G protein-coupled receptor 173 |
chr21_-_45671014 | 0.41 |
ENST00000436357.1
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like |
chr1_-_228604328 | 0.40 |
ENST00000355586.4
ENST00000366698.2 ENST00000520264.1 ENST00000479800.1 ENST00000295033.3 |
TRIM17
|
tripartite motif containing 17 |
chr1_+_160051319 | 0.40 |
ENST00000368088.3
|
KCNJ9
|
potassium inwardly-rectifying channel, subfamily J, member 9 |
chr12_-_57941004 | 0.40 |
ENST00000550750.1
ENST00000548249.1 |
DCTN2
|
dynactin 2 (p50) |
chr21_+_34775181 | 0.40 |
ENST00000290219.6
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr6_+_144164455 | 0.39 |
ENST00000367576.5
|
LTV1
|
LTV1 homolog (S. cerevisiae) |
chr19_+_10131437 | 0.39 |
ENST00000587782.1
|
RDH8
|
retinol dehydrogenase 8 (all-trans) |
chr3_-_48470838 | 0.39 |
ENST00000358459.4
ENST00000358536.4 |
PLXNB1
|
plexin B1 |
chr16_+_69458537 | 0.39 |
ENST00000515314.1
ENST00000561792.1 ENST00000568237.1 |
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane) |
chr12_-_57940904 | 0.39 |
ENST00000550954.1
ENST00000434715.3 ENST00000546670.1 ENST00000543672.1 |
DCTN2
|
dynactin 2 (p50) |
chr1_+_202431859 | 0.39 |
ENST00000391959.3
ENST00000367270.4 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr7_-_98741714 | 0.39 |
ENST00000361125.1
|
SMURF1
|
SMAD specific E3 ubiquitin protein ligase 1 |
chr19_+_2249308 | 0.38 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
chr9_-_34637806 | 0.38 |
ENST00000477726.1
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1 |
chr7_-_4998802 | 0.38 |
ENST00000406755.1
ENST00000404774.3 ENST00000401401.3 |
MMD2
|
monocyte to macrophage differentiation-associated 2 |
chr1_-_24126892 | 0.37 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
chr10_+_106014468 | 0.37 |
ENST00000369710.4
ENST00000369713.5 ENST00000445155.1 |
GSTO1
|
glutathione S-transferase omega 1 |
chr17_+_28886584 | 0.37 |
ENST00000584297.1
ENST00000579181.1 |
TBC1D29
|
TBC1 domain family, member 29 |
chr1_-_1149506 | 0.37 |
ENST00000379236.3
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4 |
chr16_+_640201 | 0.37 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr20_-_30310797 | 0.37 |
ENST00000422920.1
|
BCL2L1
|
BCL2-like 1 |
chr8_+_38243967 | 0.36 |
ENST00000524874.1
ENST00000379957.4 ENST00000523983.2 |
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr15_-_79383102 | 0.36 |
ENST00000558480.2
ENST00000419573.3 |
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1 |
chr3_-_43663519 | 0.36 |
ENST00000427171.1
ENST00000292246.3 |
ANO10
|
anoctamin 10 |
chr12_-_53242770 | 0.36 |
ENST00000304620.4
ENST00000547110.1 |
KRT78
|
keratin 78 |
chr19_+_45147098 | 0.36 |
ENST00000425690.3
ENST00000344956.4 ENST00000403059.4 |
PVR
|
poliovirus receptor |
chr11_-_627143 | 0.35 |
ENST00000176195.3
|
SCT
|
secretin |
chr19_-_4517613 | 0.35 |
ENST00000301286.3
|
PLIN4
|
perilipin 4 |
chr6_-_163148780 | 0.35 |
ENST00000366892.1
ENST00000366898.1 ENST00000366897.1 ENST00000366896.1 |
PARK2
|
parkin RBR E3 ubiquitin protein ligase |
chr18_-_59274139 | 0.35 |
ENST00000586949.1
|
RP11-879F14.2
|
RP11-879F14.2 |
chr1_-_201123546 | 0.34 |
ENST00000435310.1
ENST00000485839.2 ENST00000367330.1 |
TMEM9
|
transmembrane protein 9 |
chr20_+_35974532 | 0.34 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr14_-_54955721 | 0.33 |
ENST00000554908.1
|
GMFB
|
glia maturation factor, beta |
chr11_+_63753883 | 0.33 |
ENST00000538426.1
ENST00000543004.1 |
OTUB1
|
OTU domain, ubiquitin aldehyde binding 1 |
chr19_+_7733929 | 0.33 |
ENST00000221515.2
|
RETN
|
resistin |
chr12_+_57522258 | 0.33 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr22_-_38794490 | 0.33 |
ENST00000400206.2
|
CSNK1E
|
casein kinase 1, epsilon |
chr16_-_28518153 | 0.33 |
ENST00000356897.1
|
IL27
|
interleukin 27 |
chr21_+_34775772 | 0.33 |
ENST00000405436.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr20_-_30433396 | 0.33 |
ENST00000375978.3
|
FOXS1
|
forkhead box S1 |
chr1_-_201123586 | 0.33 |
ENST00000414605.2
ENST00000367334.5 ENST00000367332.1 |
TMEM9
|
transmembrane protein 9 |
chr16_+_33204980 | 0.32 |
ENST00000561509.1
|
TP53TG3C
|
TP53 target 3C |
chr22_+_21400229 | 0.32 |
ENST00000342608.4
ENST00000543388.1 ENST00000442047.1 |
AC002472.13
|
Leucine-rich repeat-containing protein LOC400891 |
chr5_-_141060389 | 0.32 |
ENST00000504448.1
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr7_-_752577 | 0.32 |
ENST00000544935.1
ENST00000430040.1 ENST00000456696.2 ENST00000406797.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
chr19_+_45973120 | 0.32 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr11_-_71955210 | 0.32 |
ENST00000298231.5
|
PHOX2A
|
paired-like homeobox 2a |
chr1_+_1950763 | 0.32 |
ENST00000378585.4
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta |
chr19_+_45582453 | 0.31 |
ENST00000591607.1
ENST00000591747.1 ENST00000270257.4 ENST00000391951.2 ENST00000587566.1 |
GEMIN7
MARK4
|
gem (nuclear organelle) associated protein 7 MAP/microtubule affinity-regulating kinase 4 |
chr15_+_42694573 | 0.31 |
ENST00000397200.4
ENST00000569827.1 |
CAPN3
|
calpain 3, (p94) |
chr1_-_32110467 | 0.31 |
ENST00000440872.2
ENST00000373703.4 |
PEF1
|
penta-EF-hand domain containing 1 |
chr19_-_2050852 | 0.31 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr12_+_58166370 | 0.31 |
ENST00000300209.8
|
METTL21B
|
methyltransferase like 21B |
chr1_-_31661000 | 0.31 |
ENST00000263693.1
ENST00000398657.2 ENST00000526106.1 |
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
chr19_-_49567124 | 0.31 |
ENST00000301411.3
|
NTF4
|
neurotrophin 4 |
chr9_-_35112376 | 0.31 |
ENST00000488109.2
|
FAM214B
|
family with sequence similarity 214, member B |
chr19_+_11039391 | 0.30 |
ENST00000270502.6
|
C19orf52
|
chromosome 19 open reading frame 52 |
chr6_-_32908765 | 0.30 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chr2_+_220492373 | 0.30 |
ENST00000317151.3
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr1_-_115300579 | 0.30 |
ENST00000358528.4
ENST00000525132.1 |
CSDE1
|
cold shock domain containing E1, RNA-binding |
chr1_+_35544968 | 0.30 |
ENST00000359858.4
ENST00000373330.1 |
ZMYM1
|
zinc finger, MYM-type 1 |
chr17_-_7307358 | 0.30 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr13_-_24007815 | 0.30 |
ENST00000382298.3
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
chr10_+_98064085 | 0.29 |
ENST00000419175.1
ENST00000371174.2 |
DNTT
|
DNA nucleotidylexotransferase |
chr22_-_18257178 | 0.29 |
ENST00000342111.5
|
BID
|
BH3 interacting domain death agonist |
chr1_-_209824643 | 0.29 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr14_-_36988882 | 0.29 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr9_+_103189536 | 0.28 |
ENST00000374885.1
|
MSANTD3
|
Myb/SANT-like DNA-binding domain containing 3 |
chr11_-_72353451 | 0.28 |
ENST00000376450.3
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr14_+_100150622 | 0.28 |
ENST00000261835.3
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1 |
chr14_-_107211459 | 0.28 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr19_+_41103063 | 0.28 |
ENST00000308370.7
|
LTBP4
|
latent transforming growth factor beta binding protein 4 |
chr1_-_43638168 | 0.27 |
ENST00000431635.2
|
EBNA1BP2
|
EBNA1 binding protein 2 |
chr19_+_14640372 | 0.27 |
ENST00000215567.5
ENST00000598298.1 ENST00000596073.1 ENST00000600083.1 ENST00000436007.2 |
TECR
|
trans-2,3-enoyl-CoA reductase |
chr9_+_139839711 | 0.27 |
ENST00000224181.3
|
C8G
|
complement component 8, gamma polypeptide |
chr21_-_45681765 | 0.26 |
ENST00000431166.1
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like |
chr1_-_115300592 | 0.26 |
ENST00000261443.5
ENST00000534699.1 ENST00000339438.6 ENST00000529046.1 ENST00000525970.1 ENST00000369530.1 ENST00000530886.1 |
CSDE1
|
cold shock domain containing E1, RNA-binding |
chr16_+_765092 | 0.26 |
ENST00000568223.2
|
METRN
|
meteorin, glial cell differentiation regulator |
chr7_-_92107229 | 0.26 |
ENST00000603053.1
|
ERVW-1
|
endogenous retrovirus group W, member 1 |
chr19_+_56116771 | 0.26 |
ENST00000568956.1
|
ZNF865
|
zinc finger protein 865 |
chr16_+_84224780 | 0.26 |
ENST00000315906.5
|
ADAD2
|
adenosine deaminase domain containing 2 |
chr15_+_91478493 | 0.26 |
ENST00000418476.2
|
UNC45A
|
unc-45 homolog A (C. elegans) |
chr8_-_87081926 | 0.26 |
ENST00000276616.2
|
PSKH2
|
protein serine kinase H2 |
chr19_+_17186577 | 0.25 |
ENST00000595618.1
ENST00000594824.1 |
MYO9B
|
myosin IXB |
chrX_+_51927919 | 0.25 |
ENST00000416960.1
|
MAGED4
|
melanoma antigen family D, 4 |
chr20_+_52824367 | 0.25 |
ENST00000371419.2
|
PFDN4
|
prefoldin subunit 4 |
chr2_+_48757278 | 0.25 |
ENST00000404752.1
ENST00000406226.1 |
STON1
|
stonin 1 |
chr2_-_88285309 | 0.24 |
ENST00000420840.2
|
RGPD2
|
RANBP2-like and GRIP domain containing 2 |
chr2_-_85829496 | 0.24 |
ENST00000409668.1
|
TMEM150A
|
transmembrane protein 150A |
chr1_+_87595497 | 0.23 |
ENST00000471417.1
|
RP5-1052I5.1
|
long intergenic non-protein coding RNA 1140 |
chr16_+_84224740 | 0.23 |
ENST00000268624.3
|
ADAD2
|
adenosine deaminase domain containing 2 |
chr9_+_139839686 | 0.23 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
chr19_-_38397228 | 0.23 |
ENST00000447313.2
|
WDR87
|
WD repeat domain 87 |
chr20_-_34638841 | 0.23 |
ENST00000565493.1
|
LINC00657
|
long intergenic non-protein coding RNA 657 |
chr13_+_47127322 | 0.22 |
ENST00000389798.3
|
LRCH1
|
leucine-rich repeats and calponin homology (CH) domain containing 1 |
chr9_-_34710066 | 0.22 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
chr6_+_43044003 | 0.22 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
chr1_+_87595433 | 0.22 |
ENST00000469312.2
ENST00000490006.2 |
RP5-1052I5.1
|
long intergenic non-protein coding RNA 1140 |
chr5_-_180237445 | 0.22 |
ENST00000393340.3
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr19_-_3772209 | 0.22 |
ENST00000555978.1
ENST00000555633.1 |
RAX2
|
retina and anterior neural fold homeobox 2 |
chr13_-_46425865 | 0.22 |
ENST00000400405.2
|
SIAH3
|
siah E3 ubiquitin protein ligase family member 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.1 | 3.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.7 | 2.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 1.9 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.6 | 2.2 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.4 | 1.3 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.5 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.4 | 1.1 | GO:2000646 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 3.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) positive regulation of axon regeneration(GO:0048680) action potential propagation(GO:0098870) |
0.3 | 1.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 1.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.2 | 0.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.1 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 0.6 | GO:1900126 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 0.7 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.2 | 0.5 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.4 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.1 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 1.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.1 | 0.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.1 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.3 | GO:2000196 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
0.1 | 1.5 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.3 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.1 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.7 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 0.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.1 | 0.2 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 1.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.3 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 1.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.0 | 0.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 1.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 1.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
0.0 | 0.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.0 | 0.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.0 | 0.1 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.0 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 1.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.1 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.0 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.1 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.4 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.0 | 0.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.0 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.0 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 0.7 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 2.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 4.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.3 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.7 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 3.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 1.5 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 2.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.1 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 1.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 1.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.6 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 1.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 1.9 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.5 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.8 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.3 | 3.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 0.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 1.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 1.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.3 | 1.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 0.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.2 | 0.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 1.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
0.1 | 1.6 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 3.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 0.4 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 3.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 1.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.1 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 1.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 4.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 2.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |